2015 Conferences and Events > 21st Annual Conference of the British HIV Association (Brighton 2015) > 21st Annual Conference of BHIVA - Presentations >

21st Annual Conference of BHIVA Presentations - Thursday 23 April 2015

Date: 21 - 24 April 2015

Venue: The Brighton Centre, Brighton, UK

Please click on an icon to download a file.

BHIVA Plenary Session 2: Managing and commissioning HIV services

Dr James Palmer Commissioning HIV services in the NHS: which model is best?
Dr James Palmer, NHS England

Professor Brian Angus Too many reviews; too much monitoring
Professor Brian Angus, University of Oxford

Oral Research Presentations: Session 2 - Antiretroviral Therapy

Dr Colette Smith Abstract O7: Enhanced immune reconstitution with initiation of ART at HIV-1 seroconversion (PHI)
Dr Colette Smith, University College London

Dr Julie Fox Abstract O8: A Phase IV HIV PrEP study reveals limited ex vivo potency of oral Maraviroc against HIV-1
Dr Julie Fox, Guys' & St Thomas' NHS Foundation Trust, London

Dr Francesca Ferretti Abstract O9: Cerebrospinal fluid markers in long-term atazanavir/ritonavir monotherapy
Dr Francesca Ferretti, San Raffaele Scientific Institute, Milan, Italy

Dr Andrew Hill Abstract O10: No difference in risk of virological failure between antiretroviral treatments using co-formulated versus individual drugs: Meta-analysis of 9 randomised trials in 2,568 patients
Dr Andrew Hill, Chelsea & Westminster Hospital, London

Dr Juan Tiraboschi Abstract O11: The impact of boosted darunavir monotherapy on neurocognitive function and quality of life: Results from a prospective randomised study
Dr Juan Tiraboschi, Guys & St Thomas' NHS Foundation Trust, London

Dr Alison Brown Abstract O12: Increasing uptake and adherence to ART initiated at a CD4>350: Data from the comprehensive national cohort of people living with diagnosed HIV infection
Dr Alison Brown, Public Health England

Dr Julie Fox Abstract O13: UK clinicians’ approach to ART in primary HIV infection; comparison with the BHIVA guidelines
Dr Julie Fox, Guys' & St Thomas' NHS Foundation Trust, London

Dr Helen Iveson Abstract O14: Effects of long-standing antiretroviral therapy on semen HIV viral load
Dr Helen Iveson, Guy's & St Thomas' NHS Foundation Trust, London

Miss Anna Tostevin Abstract O15: Trends in transmitted drug resistance to HIV-1 in the UK since 2010
Miss Anna Tostevin, MRC Clinical Trials Unit at UCL

BHIVA Lunchtime Workshop 3 - Difficult pharmacology case presentations

Pharmacological considerations in HIV co-infected with MDR TB
Dr Derek Cocker, Royal Liverpool University Hospital

A real QT
Dr Nadia Ahmed, Central and Northwest London NHS Foundation Trust

Sex, drugs and rhabdomyolysis
Dr Subathira Dakshina, Barts Health NHS Trust, London

BHIVA Lunchtime Workshop 4 - BHIVA/UK-CAB Community Workshop: HIV-related stigma; influencing and changing attitudes

Dr Nina Pearson
Luton Clinical Commissioning Group

Mrs Fiona Wallis
Monkgate Health Centre, York

Oral Research Presentations: Session 3 - Basic Science and Co-morbidities

Dr Caroline Foster Abstract O16: Early antiretroviral therapy reduces HIV-1 DNA following perinatal HIV-1 infection
Dr Caroline Foster, Imperial College Healthcare NHS Trust, London

Dr Jaime Vera Abstract O17: Microbial translocation is associated with neuroinflammation in HIV subjects on ART
Dr Jaime Vera, Imperial College London

Dr Benedict Michael Abstract O18: CSF:plasma HIV-1 RNA discordance >0.5log10 is associated with raised inflammatory mediator profiles in CSF
Dr Benedict Michael, University of Liverpool

Dr Olubanke Davies Abstract O19: Impact of rectal gonorrhoea and chlamydia on HIV viral load and inflammatory markers in the rectum; potential significance for onward transmission
Dr Olubanke Davies, Guy's & St Thomas' NHS Foundation Trust, London

Ms Alicia Thornton Abstract O20: Treatment for hepatitis C infection in the UK Collaborative HIV Cohort (UK CHIC) study
Ms Alicia Thornton, University College London

Dr Serena Venturelli Abstract O21: The exclusion of people living with HIV (PLWH) from clinical trials in lymphoma: prejudice or justified?
Dr Serena Venturelli, Chelsea & Westminster Hospital, London

Miss Sophie Jose Abstract O22: Initiation of anti-retrovirals in HIV/HCV-coinfected MSM: Are we too late?
Miss Sophie Jose, University College London

Miss Esther Gathogo Abstract O23: Risk factors for acute allograft rejection in HIV-positive kidney transplant recipients
Miss Esther Gathogo, King's College London

Dr Amanda Samarawickrama Abstract O24: No association between vitamin D deficiency and parathyroid hormone, bone density and bone turnover in a large cohort of HIV-infected men on tenofovir
Dr Amanda Samarawickrama, Brighton and Sussex Medical School

BHIVA Audit Session

Dr Sonia Raffe Audit of Management of Pregnancy in HIV
Dr Sonia Raffe, Royal Sussex County Hospital, Brighton

BHIVA Plenary Session 3: Clinical management

Dr Sanjay Bhagani Update on the management of opportunistic infections
Dr Sanjay Bhagani, Royal Free Hospital, London

Professor Priscilla Hsue Vasculitis and HIV
Professor Priscilla Hsue, University of California, San Francisco, USA